The case for nocturnal hemodialysis.
Pierratos
A
A
Humber River Regional Hospital, University of Toronto, Canada.
D000740:Anemia / Q000188:drug therapy; D001794:Blood Pressure; D002405:Catheterization, Central Venous; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000517:prevention & control; D003072:Cognition Disorders / Q000628:therapy; D003365:Costs and Cost Analysis; D017743:Equipment Reuse; D006437:Hemodialysis, Home / Q000191:economics / Q000379:methods*; D006760:Hospitalization; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008991:Monitoring, Physiologic; D009747:Nutritional Physiological Phenomena; D010353:Patient Education as Topic; D010710:Phosphates / Q000097:blood; D011788:Quality of Life; D012893:Sleep Wake Disorders / Q000628:therapy; D015996:Survival Rate; D017216:Telemedicine; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000097:blood
D010710:Phosphates; D001613:beta 2-Microglobulin